Content deleted Content added
Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: InChI1->InChI StdInChI StdInChIKey. |
|||
(30 intermediate revisions by 23 users not shown) | |||
Line 1:
{{Short description|Chemical compound}}
{{Drugbox
|IUPAC_name = ▼
| verifiedrevid = 444022443
| image=Naltriben.png▼
▲| IUPAC_name =
| ChemSpiderID = 4589081▼
| InChI = 1/C26H25NO4/c28-18-8-7-15-11-20-26(29)12-17-16-3-1-2-4-19(16)30-22(17)24-25(26,21(15)23(18)31-24)9-10-27(20)13-14-5-6-14/h1-4,7-8,14,20,24,28-29H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1▼
| alt = Skeletal formula
| width = 215
| image2 = Naltriben molecule ball.png
| StdInChIKey = ZHVWWEYETMPAMX-IFKAHUTRSA-N▼
| alt2 = Ball-and-stick model of naltriben
| CAS_number= 111555-58-9▼
| ATC_prefix= none▼
<!--Clinical data-->| tradename =
| routes_of_administration = <!--Pharmacokinetic data-->▼
| PubChem= 5486827▼
| metabolism = ▼
| IUPHAR_ligand = 1640▼
| excretion = <!--Identifiers-->
▲| CAS_number = 111555-58-9
| smiles = Oc3c2O[C@H]6c1oc8ccccc8c1C[C@@]5(O)[C@H]4N(CC[C@@]56c2c(cc3)C4)CC7CC7▼
| CAS_number_Ref = {{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = RXG719F189
▲| metabolism =
▲| ATC_prefix = none
▲| PubChem = 5486827
▲| IUPHAR_ligand = 1640
▲| routes_of_administration=
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
▲| ChemSpiderID = 4589081
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| PDB_ligand = ZY8
| ChEMBL = 100940
<!--Chemical data-->| C = 26
| H = 25
| N = 1
| O = 4
▲| smiles = Oc3c2O[C@H]6c1oc8ccccc8c1C[C@@]5(O)[C@H]4N(CC[C@@]56c2c(cc3)C4)CC7CC7
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
▲|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
▲| StdInChIKey = ZHVWWEYETMPAMX-IFKAHUTRSA-N
}}
'''Naltriben''' is a potent and selective [[competitive antagonist|antagonist]] for the [[delta opioid receptor]], which is used in scientific research. It has similar effects to the more widely used δ antagonist [[naltrindole]], but with different binding affinity for the δ<sub>1</sub> and δ<sub>2</sub> subtypes, which makes it useful for distinguishing the subtype selectivity of drugs acting at the δ receptors.<ref>{{cite journal | vauthors = Sofuoglu M, Portoghese PS, Takemori AE
== See also ==
* [[Nalfurafine]]
* [[Nalmefene]]
* [[Naltrindole]]
== References ==
{{Reflist}}
{{
[[Category:
[[Category:
[[Category:
[[Category:Hydroxyarenes]]
[[Category:Tertiary alcohols]]
[[Category:Kappa-opioid receptor agonists]]
[[Category:Semisynthetic opioids]]
[[Category:Cyclopropyl compounds]]
|